ArticlePharmaceutical research2022

Pharmacokinetics and Pharmacodynamic Effect of a Blood-Brain Barrier-Crossing Fusion Protein Therapeutic for Alzheimer's Disease in Rat and Dog.

Etienne Lessard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.